Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Neuroendocrine Tumors
NCT00003514Phase 2Withdrawn
- Sponsor
- Burzynski Research Institute
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in Neuroendocrine Neoplasm (NEN), sponsored by Burzynski Research Institute. Status: withdrawn.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT00003514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003514.